According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Patients older than 65 years had similar clinical outcomes in response to immune checkpoint inhibitors as younger patients with cancer.

It had been hoped that RA patients might actually benefit more from these drugs, known as immune checkpoint inhibitors (ICIs) ...

Study Identifies Subtypes of Fibroblasts in Skin Cancer Nov. 19 ... melanoma treated with a combination of immune checkpoint inhibitors survive cancer-free for 10 years or ...

Patients who were positive for cytomegalovirus had more immune cells circulating in their blood before they started ...

The majority of patients with advanced melanoma who stop treatment with immune checkpoint inhibitor therapies remain relapse-free.

Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.

Trials of IFx-Hu2.0 are initiating, looking to overcome checkpoint inhibitor resistance in Merkel cell carcinoma.

This innovative approach challenges the standard treatment path for many cancer patients, which typically includes surgery followed by chemotherapy and radiation. For patients facing difficult ...

During the second half of 2025, Werewolf plans to present interim data from the monotherapy and combination expansion arms, including tolerability, response rate, and durability, and to engage with ...